Pediatric Neurology News

Natalia S. Rost, MD, MPH, chair of the AAN science committee, led a discussion to highlight select studies being presented at the AAN’s annual meeting April 2-7 in Seattle.

Pediatric ischemic stroke increases the risk for autism, especially in children with comorbid epilepsy, according to results of a Swedish cohort study published in Neurology.

Concussion was linked to increased risk for mental health issues, psychiatric hospitalization and self-harm among youths aged 5 to 18 years, according to results of a population-based retrospective cohort study.

Healio’s most-viewed neurology stories in February highlight evidence of potential dangers of marijuana for brain health, the FDA expanding the indication of a hemorrhage detection device and an NIH grant to a biotech firm.

Surgical therapy yielded lower long-term health care costs compared with medical therapy in children with drug-resistant epilepsy, according to a Canadian study published in Neurology.

The FDA granted expanded indication to Infrascanner, a handheld device used for detecting traumatic supratentorial hematomas in adults, to now include pediatric patients aged 2 years and older.

In a new statement, the American Heart Association presented scientific evidence that challenges the belief that marijuana is harmless and highlights uncertainty about the drug’s effect on brain health.

The COVID-19 pandemic has significantly altered delivery of developmental services among children with acute provoked neonatal seizures, according to results of a prospective cohort study published in Pediatric Neurology.

Healio’s most-viewed neurology stories in January highlight several FDA developments, a Medicare proposal to limit Aduhelm coverage and a study on the role of Epstein-Barr virus infection in MS.

The FDA has granted priority review to PTC Therapeutics Inc. for a supplemental new drug application regarding Evrysdi, according to a company release.